NASDAQ · Financial Statements

Cellebrite DI Ltd. (CLBT) Financial Statements

$12.10 NASDAQ: CLBT Market Cap $3.04B

Cellebrite DI Ltd. most recently reported annual revenue of $476.0M, net profit of $78.0M. Revenue grew at an average annual rate of 19.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Cellebrite DI Ltd.: Revenue rose from $172.0M in 2019 to $476.0M in 2025, a change of +176.7% over 6 years; net profit was positive in 4 of 7 reported years; operating margin moved from -0.9% to 14.0%, a shift of +14.9 percentage points; the most recent year shows net profit of $78.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$172.0M$195.0M$246.0M$271.0M$325.0M$401.0M$476.0M
Operating Expenses$173.0M$186.0M$232.0M$270.0M$292.0M$344.0M$409.0M
Operating Profit$-2.0M$9.0M$14.0M$1.0M$33.0M$57.0M$66.0M
Operating Margin-0.9%4.7%5.6%0.4%10.2%14.2%14.0%
Other Income$3.0M$2.0M$68.0M$120.0M$-109.0M$-333.0M$24.0M
Interest$0$1.0M$0$0$0$350.0M$0
Depreciation$4.0M$6.0M$7.0M$9.0M$10.0M$11.0M$12.0M
Profit Before Tax$1.0M$11.0M$82.0M$121.0M$-76.0M$-276.0M$91.0M
Tax$232.6M$49.3M$13.3M$-40,000$-7.3M$-2.5M$13.6M
Net Profit$-2.0M$6.0M$71.0M$121.0M$-81.0M$-283.0M$78.0M
EPS$-0.05$-0.05$0.44$0.59$-0.43$-1.35$0.31
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$84.0M$93.0M$90.0M$96.0M$107.0M$109.0M$108.0M$113.0M$126.0M$129.0M$128.0M$131.0M
Operating Expenses$71.0M$78.0M$80.0M$83.0M$87.0M$93.0M$95.0M$99.0M$107.0M$108.0M$119.0M$124.0M
Operating Profit$13.0M$15.0M$9.0M$12.0M$19.0M$16.0M$12.0M$14.0M$19.0M$21.0M$9.0M$8.0M
Operating Margin16.0%16.1%10.3%13.1%18.2%14.4%11.4%12.7%15.1%16.1%7.1%5.8%
Interest$7.0M$27.0M$79.0M$35.0M$224.0M$0$0$0$0$0$0$0
Profit Before Tax$7.0M$-12.0M$-69.0M$-22.0M$-205.0M$20.0M$19.0M$21.0M$24.0M$26.0M$14.0M$11.0M
Tax$5.1M$-18.6M$-3.0M$-8.2M$-1.3M$3.2M$10.0M$6.3M$16.9M$19.1M$19.8M$43.0M
Net Profit$7.0M$-15.0M$-71.0M$-24.0M$-207.0M$19.0M$17.0M$19.0M$20.0M$21.0M$11.0M$6.0M
EPS$0.03$-0.08$-0.36$-0.12$-0.99$0.08$0.07$0.08$0.08$0.08$0.04$0.03

Over the 7 years reported for Cellebrite DI Ltd., cash stood at $124.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.56 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$280.0M$364.0M$340.0M$403.0M$533.0M$691.0M$939.0M
Current Assets$262.0M$324.0M$273.0M$296.0M$422.0M$568.0M$576.0M
Cash$77.0M$129.0M$146.0M$88.0M$190.0M$192.0M$124.0M
Inventory$4.0M$5.0M$7.0M$10.0M$10.0M$9.0M$8.0M
Receivables$44.0M$66.0M$68.0M$79.0M$77.0M$82.0M$105.0M
Fixed Assets$15.0M$16.0M$17.0M$33.0M$30.0M$28.0M$39.0M
Capital Work in Progress$0$0$0$0$0$0$0
Investments$124.0M$109.0M$36.0M$118.0M$142.0M$292.0M$411.0M
Other Assets$0$9.0M$27.0M$27.0M$27.0M$29.0M$120.0M
Total Liabilities$221.0M$301.0M$413.0M$329.0M$499.0M$355.0M$455.0M
Current Liabilities$99.0M$159.0M$187.0M$208.0M$254.0M$296.0M$370.0M
Borrowings$0$0$0$15.0M$14.0M$11.0M$23.0M
Other Liabilities$221.0M$301.0M$413.0M$314.0M$485.0M$344.0M$432.0M
Equity$0$0$0$0$0$0$0
Reserves$59.0M$64.0M$-73.0M$74.0M$34.0M$336.0M$484.0M

For Cellebrite DI Ltd., operating cash flow was positive in 7 of 7 reported years; free cash flow in the latest year was $156.0M; free cash flow was positive in 7 of 7 years.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow$16.0M$67.0M$36.0M$21.0M$102.0M$132.0M$169.0M
Investing Cash Flow$-53.0M$-13.0M$37.0M$-100.0M$-30.0M$-160.0M$-281.0M
Financing Cash Flow$-1.0M$1.0M$32.0M$14.0M$22.0M$21.0M$0
Net Cash Flow$45.0M$52.0M$12.0M$-58.0M$102.0M$2.0M$-67.0M
Free Cash Flow$10.0M$60.0M$28.0M$11.0M$94.0M$122.0M$156.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.55
EV / EBITDA23.55
FCF Yield5.00%
Quick Ratio1.58
Interest Coverage—
Return 1Y2.23%
Return 3Y92.38%
Return 5Y47.28%

Cellebrite DI Ltd. (CLBT) financials — frequently asked questions

What is Cellebrite DI Ltd.'s annual revenue?

Cellebrite DI Ltd. (CLBT) reported annual revenue of $476.0M in its most recent fiscal year.

What is Cellebrite DI Ltd.'s net profit?

Cellebrite DI Ltd. (CLBT) reported net profit of $78.0M in its most recent fiscal year.

What is CLBT EV/EBITDA?

Cellebrite DI Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is 23.55.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
CLBT Overview CLBT Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.